已收盤 02-06 16:00:00 美东时间
-0.210
-1.03%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and maintains $28 price target.
2025-12-18 03:37
HealthStream (NASDAQ:HSTM) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.17 by 17.65 percent. This is a 5.26 percent increase over earnings of $0.19 per share from the
2025-11-04 05:30
HealthStream (NASDAQ:HSTM) on Wednesday said that it has acquired Virsys12, a provider data management company, for up to $17 million in cash. The deal will enhance HealthStream’s credentialing suite,...
2025-10-09 04:13
NASHVILLE, Tenn.--(BUSINESS WIRE)-- HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for workforce solutions, today announced that it has acquired Virsys12, a healthcare technology company
2025-10-09 04:06
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
2025-08-08 09:34
Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and lowers the price target from $29 to $28.
2025-08-08 06:17
Healthstream ( ($HSTM) ) has released its Q2 earnings. Here is a breakdown of t...
2025-08-06 11:59
HealthStream (NASDAQ:HSTM) affirms FY2025 sales outlook from $297.500 million-$303.500 million to $297.500 million-$303.500 million vs $300.236 million estimate.
2025-08-05 04:32
HealthStream (NASDAQ:HSTM) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.15 by 16.13 percent. This is a 12.5 percent increase over earnings of $0.16 per share from the
2025-08-05 04:31